Here are four things to know.
- In the third quarter of 2016, J&J’s global sales increased by 5.9 percent, domestic sales jumped by 7.3 percent and international sales rose by 4.2 percent, excluding the net impact of acquisitions, divestitures and hepatitis C sales.
- Operational sales results jumped 4.3 percent in the third quarter of 2016, compared to the same period the year prior.
- J&J’s net earnings and diluted earnings per share for the third quarter of 2016 were $4.3 billion and $1.53, respectively, according to the report.
- J&J projects sales of $71.5 to $72.2 billion for the full 2016 year.
More articles on supply chain:
NeoGrid expands supply chain services: 3 things to know
Prescription drug costs see largest jump in 24 years
Texas Medical Center partners with J&J to develop medical devices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
